CCL28 and cancer: Pursuant to the previous research’s findings and the present investigation, we showed that Anti-miR-21 enforces anti-cancer efficacy via particular upregulation of hub genes, include CCL28, NR3C2, and SYNPO2. These results may simplify the further method for finding new therapeutic approaches in GC.